Some other commonly reported side effects have been loss of muscle mass, abdominal pain, vomiting, diarrhea, and depression
Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of Glucagon-like Peptide1 Receptor Agonist Therapies
In that case, your clinician may refer you to a gastroenterologist for tests that rule out other causes, such as: Infections Bile acid malabsorption New-onset inflammatory conditions Why Does Tirzepatide Cause Diarrhea
This new drug is a dual-agonist, which means it contains not only a GLP-1 agonist but another drug called glucose-dependent insulinotropic peptide (GIP), and the safety and benefit profile is really quite impressive. Early studies have shown it may work even better than Ozempic and Wegovy
Engineering bimodal molecules that integrate GLP-1R agonism with specific pain-related mechanisms may offer innovative therapeutic options